Cotización Philogen - PHIL

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

19.00

Postura de Compra

18.55

Postura de Venta

19.10

Volume Operado de la Acción

5,668

18.55 Rango del Día 19.50

16.30 Rango de 52 semanas 21.90

Capitalización de Mercado [m]

767.554M

Precio Anterior

19.10

Precio de Apertura

19.50

Hora

878

19.1

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

8,290

Acciones en circulación

40,397,605

Rendimiento del Dividendo

Ratio Precio/Utilidad

0.00

Beneficio por acción (BPA)

turnover

25.12M

Beneficio neto

-6.16M

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.philogen.com

Sede

Siena, Siena, Ita

Fundado

Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 19.10 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

Philogen currently has 40,397,605 shares in issue. The market capitalisation of Philogen is 771.59 € million.

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.35	1.87667560322	18.65	19.75	18.05	4839	18.59734047	DE
4	-0.95	-4.7619047619	19.95	20	18.05	6056	19.02868083	DE
12	-1.1	-5.47263681592	20.1	21.3	18.05	8290	19.73256531	DE
26	-1.3	-6.4039408867	20.3	21.9	18.05	6512	20.08872547	DE
52	0.9	4.97237569061	18.1	21.9	16.3	8697	19.02855775	DE
156	4.98	35.5206847361	14.02	21.9	13	8817	16.77987179	DE
260	2	11.7647058824	17	21.9	12.6	12172	16.01515378	DE

PHIL - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Philogen?

El precio actual de las acciones de Philogen es 19.00 €

¿Cuántas acciones de Philogen están en circulación?

Philogen tiene 40,397,605 acciones en circulación

¿Cuál es la capitalización de mercado de Philogen?

La capitalización de mercado de Philogen es EUR 771.59M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Philogen?

Philogen ha negociado en un rango de 16.30 € a 21.90 € durante el último año

¿Cuál es la moneda de reporte de Philogen?

Philogen presenta sus resultados financieros en EUR

¿Cuál es el último ingresos anual de Philogen?

El último ingresos anual de Philogen es EUR 25.12M

¿Cuál es el último beneficio anual de Philogen?

El último beneficio anual de Philogen es EUR -6.16M

¿Cuál es la dirección registrada de Philogen?

La dirección registrada de Philogen es PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100

¿Cuál es la dirección del sitio web de Philogen?

La dirección del sitio web de Philogen es www.philogen.com

¿En qué sector industrial opera Philogen?

Philogen opera en el sector PHARMACEUTICAL PREPARATIONS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
WFTC26Finanzatech Spa	0.025 € (26.26%)	40
WART28DeodatoGallery SpA	0.0558 € (24.00%)	27.4k
WFAE25Fae Technology	0.50 € (16.23%)	20
WSGC28SG Company SpA	0.0294 € (13.51%)	1,000
WPOZ27Pozzi Milano Spa	0.102 € (13.33%)	14.05k
WPSQ26Pasquarelli Auto SpA	0.0109 € (-44.10%)	923
1CDECoeur Mining Inc	5.51 € (-20.63%)	500
1WCHWacker Chemie AG	67.50 € (-18.28%)	218
WTFINTrevi Finanziaria Industriale Spa	1.011 € (-17.54%)	2.42k
EPHEPH SpA	0.1002 € (-16.50%)	6.72k
TITTelecom Italia SpA	0.243 € (-3.19%)	370.41M
ISPIntesa Sanpaolo Spa	3.841 € (-0.31%)	137.21M
SPMSaipem Spa	2.484 € (-6.02%)	64.72M
TITRTelecom Italia	0.2813 € (-3.10%)	47.53M
ENELEnel Spa	6.804 € (0.04%)	42.28M